Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseaseFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, dermatomyositis, diffuse scleroderma, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nephritis, nervous system disorder, neuromuscular disease, polymyositis, skin disorder, systemic lupus erythematosus, systemic sclerosis, urinary system disorderRecruitingPhase 12026-09-10NCT07085104

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Allogene Therapeutics5

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Astera Cancer CareEast BrunswickUnited States38
Atrium Health Rheumatology-SouthparkCharlotteUnited States1
Duke University Medical CenterDurhamUnited States505
Hôpital Maisonneuve RosemontMontrealCanada2
Icahn School of Medicine at Mount SinaiNew YorkUnited States342
Johns Hopkins HospitalBaltimoreUnited States7
LDS Hospital - lntermountain HealthSalt Lake CityUnited States1
Loma Linda University Medical CenterLoma LindaUnited States134
Mayo ClinicPhoenixUnited States50
Mayo ClinicJacksonvilleUnited States122
Medical University of South CarolinaCharlestonUnited States1
Norton Cancer Institute, St. Matthews CampusLouisvilleUnited States9
Prisma HealthGreenvilleUnited States1
The University of Chicago Medical CenterChicagoUnited States33
University of Colorado DenverAuroraUnited States46
University of IowaIowa CityUnited States284
University of Kansas Medical CenterKansas CityUnited States240